OOIR: Observatory of International Research

Papers

(The H4-Index of Biochimica et Biophysica Acta-Reviews on Cancer is 43. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Tumour cell-induced platelet aggregation in breast cancer: Scope of metal nanoparticles	277
TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance	229
Spatiotemporal dynamics of the pre-metastatic niche: remodeling of lung microenvironment before breast cancer metastasis and targeted intervention strategies	215
Uveal melanoma modeling in mice and zebrafish	183
Reflections on drug resistance to KRAS inhibitors and gene silencing/editing tools for targeting mutant KRAS in cancer treatment	160
VISTA as a context-dependent immune checkpoint: Implications for tumor immunity and autoimmune pathogenesis	115
Progress and challenges of immunotherapy in triple-negative breast cancer	105
Modeling bladder cancer in the laboratory: Insights from patient-derived organoids	99
Is tumour-expressed aminopeptidase N (APN/CD13) structurally and functionally unique?	93
ESR1 activating mutations: From structure to clinical application	93
Unlocking the power of innate lymphoid cell plasticity in the tumor microenvironment: A revolutionary pathway for cancer immunotherapy	89
Nutrition and dietary restrictions in cancer prevention	85
miRNAs and androgen deprivation therapy for prostate cancer	84
Advances in epigenetic modifications and cervical cancer research	79
Microbial influence on triggering and treatment of host cancer: An intestinal barrier perspective	77
Decoding the role of FOXP3 in esophageal cancer: Underlying mechanisms and therapeutic implications	73
Epigenetic changes associated with Bacillus Calmette-Guerin (BCG) treatment in bladder cancer	66
In what area of biology has a “new” type of cell death been discovered?	65
Insights into the role of connexins and specialized intercellular communication pathways in breast cancer: Mechanisms and applications	65
Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature	62
Biomarkers in high grade serous ovarian cancer	60
Contribution of CXCR3-mediated signaling in the metastatic cascade of solid malignancies	54
Targeting lipid metabolism in cancer metastasis	54
The VEGF/VEGFR2 system in ovarian cancer: From functional to pharmacological significance	52
Fascin-1 in primary liver cancers, perspectives for targeted therapy	51

Exploring synthetic lethality in cancer therapy: CRISPR-Cas9 technology offers new hope	50
Mitochondrial metabolism in laryngeal cancer: therapeutic mechanisms and prospects	49
Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights	49
CCL20-CCR6 signaling in tumor microenvironment: Functional roles, mechanisms, and immunotherapy targeting	48
Extracellular vesicles in cancer therapy: Roles, potential application, and challenges	47
Transcription factors in glioblastoma – Molecular pathogenesis and clinical implications	47
Advances and prospects of mRNA vaccines in cancer immunotherapy	46
Recent insights into RNA m5C methylation modification in hepatocellular carcinoma	46
Long non-coding RNAs: Fundamental regulators and emerging targets of cancer stem cells	46
S100A8 and S100A9 in Cancer	46
Multifaceted roles of neutrophils in tumor microenvironment	45
Multiple therapeutic approaches of glioblastoma multiforme: From terminal to therapy	45
Interleukin-21 as an adjuvant in cancer immunotherapy: Current advances and future directions	45
Small non-coding RNAs and pancreatic ductal adenocarcinoma: Linking diagnosis, pathogenesis, drug resistance, and therapeutic potential	45
Prognostic features of the tumour microenvironment in oesophageal adenocarcinoma	44
Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors	44
Multiple impacts of Naa10p on cancer progression: Molecular functions and clinical prospects	44
Targeting Cdc20 for cancer therapy	43
Editorial Board	43
The interplay of obesity, microbiome dynamics, and innovative anti-obesity strategies in the context of endometrial cancer progression and therapeutic approaches	43